Archives
-
ECM–Mitochondria Crosstalk in Mitochondrial Homeostasis
2026-09-02
Zhang et al. show that degradation of extracellular-matrix hyaluronan communicates environmental stress to mitochondria through TGF-β, inducing mitochondrial remodeling, mitochondrial stress responses, and stronger pathogen defense. The study positions ECM integrity as an upstream regulator of mitochondrial homeostasis and provides a framework for testing how matrix perturbations alter cellular and organismal physiology.
-
Ruthenium Red in Mechanostress Autophagy
2026-09-02
Use Ruthenium Red as a water-compatible Ca2+ transport inhibitor to test whether calcium flux contributes to compression-induced autophagy. The workflow combines mechanical stimulation, cytoskeletal analysis, calcium perturbation, and orthogonal autophagy readouts while accounting for the compound’s broad membrane activity and solution-stability limits.
-
Small-Molecule Targeting of Human ClpP: 2025 Review
2026-09-01
The 2025 Future Medicinal Chemistry review maps the design, structure–activity relationships, and pharmacology of small molecules that activate or inhibit human mitochondrial ClpP. Its central implication is that controlled activation of this mitochondrial protease can convert proteostasis and respiratory-chain vulnerabilities into experimentally testable anticancer mechanisms, while selectivity, pharmacokinetics, and safety remain major development challenges.
-
β-Blocker Selectivity in Hematopoietic Regeneration
2026-09-01
The reference study shows that nonselective β-adrenergic receptor inhibitors, unlike a β1-selective inhibitor, can delay hematopoietic recovery after allogeneic transplantation in mice and humans. Its translational implication is that β-blocker receptor selectivity may influence engraftment, particularly when posttransplant chemotherapy is used for graft-versus-host disease prophylaxis.
-
EZ Cap™ Cas9 mRNA (m1Ψ) Workflow Guide
2026-08-31
EZ Cap™ Cas9 mRNA (m1Ψ) combines a Cap1 structure, m1Ψ modification, and poly(A) tail for controlled Cas9 delivery in mammalian genome-editing workflows. This practical guide covers dose-finding, RNA handling, assay controls, nuclear-export-aware optimization, and troubleshooting without treating product specifications as universal transfection conditions.
-
UBR1 and UBR2 in ER Stress Protein Quality Control
2026-08-31
The reference study identifies the N-recognins UBR1 and UBR2 as mammalian regulators of ER stress adaptation, extending the N-degron pathway beyond its established role in substrate degradation. Loss of these E3 ligases increases sensitivity to ER stress-induced apoptosis, while stress-dependent stabilization of UBR1 and UBR2 may help preserve global protein quality control.
-
Urolithin A: From Mitophagy to Translational Strategy
2026-08-30
Urolithin A is emerging as a mechanistically interesting tool for mitochondrial quality control, linking mitophagy, mitochondrial biogenesis research, inflammation, and translational biomarker development. This article places the compound in the context of glutamine metabolism and hepatic stellate cell biology while outlining practical strategies for rigorous validation.
-
CGRP/SP–Piezo2 Signaling in Trigeminal Allodynia
2026-08-29
Liao et al. identify a Ca2+-dependent CGRP/SP–Piezo2 positive-feedback loop linking trigeminal root compression, neuroinflammation, and mechanical allodynia. Their rat and cell-based experiments position ATP, PKC, ERK1/2, and p38 MAPK as upstream regulators across a trigeminal ganglion–Merkel cell axis, providing a mechanistic framework for peripheral sensitization in trigeminal neuralgia.
-
Mitochondrial Permeability Transition Pore Assay Kit
2026-08-28
A scenario-driven guide to mitochondrial permeability transition pore detection, control design, fluorescence interpretation, and vendor selection using Mitochondrial Permeability Transition Pore Assay Kit SKU K2061. It connects Calcein AM fluorescence with practical cell viability, proliferation, and cytotoxicity workflows while distinguishing product-supported facts from laboratory recommendations.
-
Palomid 529 (P529): PI3K/Akt/mTOR Research Guide
2026-08-28
Palomid 529, also called P529, is a small-molecule dual mTORC1 and mTORC2 inhibitor used to investigate PI3K/Akt/mTOR signaling. Product information reports activity in NCI-60 cancer cells, stimulated endothelial cells, and radiation-associated angiogenic signaling, while direct validation in ESCC remains unresolved.
-
Ruthenium Red in Mechanostress Autophagy Assays
2026-08-27
Use Ruthenium Red as a practical Ca2+ transport inhibitor to test whether calcium flux links mechanical compression, cytoskeletal behavior, and autophagy. This workflow emphasizes fresh aqueous preparation, dose-response controls, orthogonal readouts, and interpretation limits across cellular, mitochondrial, sarcoplasmic reticulum, and inflammation models.
-
Tetrahydromagnolol and the Next GPCR Frontier
2026-08-27
Tetrahydromagnolol offers translational researchers a selective CB2-centered tool for connecting cannabinoid pharmacology with inflammation, pain biology, and emerging GPCR–cytoskeletal questions. This article outlines how to validate its dual CB2 agonist and GPR55 antagonist profile, interpret pathway data, and responsibly explore its relevance to metastatic cell behavior without overstating current evidence.
-
NADH: A Redox Lens on Burn Hypermetabolism
2026-08-26
NADH is more than an electron donor: it can serve as an interpretive lens for linking tissue metabolomics, mitochondrial function, and stress adaptation. This article translates randomized burn-injury research into practical NADH assay decisions while defining opportunities and limitations in disease and cancer models.
-
Interpreting In Vitro Cancer Drug Responses
2026-08-26
Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a response framework that separates proliferative arrest from cell killing and emphasizes their different proportions and timing, improving interpretation of in vitro cancer research data.
-
Streptozotocin (A4457): Reliable Assay Workflows
2026-08-25
This scenario-based guide explains how Streptozotocin supports interpretable β-cell cytotoxicity assays, experimental diabetes mellitus induction, and downstream complication studies. It combines practical optimization, data interpretation, and vendor-selection guidance for SKU A4457 without overstating what current evidence demonstrates.